CalciMedica, Inc. Shareholders' Equity
CalciMedica, Inc. (CALC) had Shareholders' Equity of $5.51 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Parent $5.51M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$1.10M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$6.64M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$268.00K.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $5.51M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | -$1.10M 10-Q · filed 2026-08-11 | |
| 2025-12-31 | -$6.64M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | -$268.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $6.10M 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $10.89M 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $14.41M 10-Q · filed 2026-08-11 | |
| 2024-09-30 | $9.03M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $13.84M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $17.25M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $8.16M 10-K · filed 2026-03-03 | |
| 2023-09-30 | $12.16M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $16.22M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $22.02M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | -$71.30M 10-K · filed 2025-03-27 | $35.97M 10-K · filed 2023-03-09 |
| 2022-09-30 | -$71.79M 10-Q · filed 2023-11-09 | $41.60M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$69.97M 10-Q · filed 2023-11-09 | $49.69M 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$67.28M 10-Q · filed 2023-11-09 | $56.26M 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$63.99M 10-K · filed 2024-03-28 | $65.02M 10-K · filed 2022-03-11 |
| 2021-09-30 | $72.14M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $78.67M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $84.56M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $94.79M 10-K · filed 2023-03-09 | |
| 2020-09-30 | $90.63M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$116.16M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | -$110.51M 10-Q · filed 2021-11-12 | |
| 2019-12-31 | -$102.95M 10-K · filed 2022-03-11 | |
| 2019-09-30 | -$92.87M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$83.04M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | -$72.92M 10-Q · filed 2020-11-12 | |
| 2018-12-31 | -$66.79M 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |